1398. Successful Treatment of primary and refractory Echinococcus (Hydatid Cyst Disease) with Mefloquine and Mebendazole

BACKGROUND: Treatment regimens for relapsed or refractory Echinococcus (Hydatid cyst disease) are not well defined. Because seropositivity for Echinococcus disease is unpredictable, insurance coverage for expensive regimens are often denied. Improved, effective regimens are needed. Recent laboratory...

Descripción completa

Detalles Bibliográficos
Autores principales: Richardson, James D, Skeen, Venus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678183/
http://dx.doi.org/10.1093/ofid/ofad500.1235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678183/
http://dx.doi.org/10.1093/ofid/ofad500.1235

Ejemplares similares